Skip to content
Home/Companies/Healthcare/PegmaTiss BioTech

PegmaTiss BioTech

Healthcare·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns PegmaTiss BioTech?

PegmaTiss BioTech is a French Healthcare company, currently owned by Erganeo since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Erganeo
Investor
Erganeo
Erganeo · 2012 · VC

Key facts

HQFrance
SectorHealthcare

More from Erganeo

Other portfolio companies in the same fund.

Greennovation
Active
France· 2025
Lafame
Active
France· 2025
Izonics
Active
IndustrialsFrance· 2022
Persea
Active
BiotechFrance· 2022
AbilyCare
Active
HealthTechFrance· 2021
Auressens
Auressens
Active
BiotechFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns PegmaTiss BioTech?

PegmaTiss BioTech is currently owned by Erganeo, through Erganeo, since 2023.

When did Erganeo acquire PegmaTiss BioTech?

Erganeo acquired PegmaTiss BioTech in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue